Kaberi Dasgupta, a physician and researcher, is Associate Professor of Medicine at McGill University and Director of the Centre for Outcomes Research and Evaluation at the Research Institute of the McGill University Health Centre. Her studies focus on the prevention and management of diabetes and its related complications. In collaboration with her multidisciplinary team, including patient partners, she develops and tests strategies to enhance self-management support.
She has over 100 peer-reviewed publications and has received research grants as principal investigator from the Canadian Institutes of Health Research, the Heart & Stroke Foundation of Canada, the Lawson Foundation, the Medavie Foundation, and Diabetes Canada. She was a recipient of a CIHR New Investigator award and has been an FRQS clinician scholar from the junior through senior levels. Her students at the MSc, PhD, and postdoctoral levels have held scholarships from CIHR, Diabetes Canada, the Heart & Stroke Foundation, and the FRQS. Some are now Assistant Professors with their own research programs at universities in Canada and the United States.
Dr Dasgupta’s notable contributions include
- The demonstration that a physician-delivered step count prescription strategy can increase steps and improve glucose control and insulin resistance in type 2 diabetes/hypertension (CIHR-funded SMARTER trial; Diabetes, Obesity & Metabolism, 2017). This strategy has been incorporated into Diabetes Canada’s 2018 Clinical Practice Guidelines.
- The determination that gestational diabetes and gestational hypertension are indicators for the future development of postpartum diabetes both in mothers and in fathers (Diabetes Canada-funded studies; Diabetes Care, 2015; American Journal of Epidemiology, 2017). This is consistent with her previous work indicating spouse concordance in diabetes (BMC Medicine, 2014). The concept of shared couple risk may be leveraged for couple-based collaboration for diabetes prevention. Dr Dasgupta has conducted several intervention studies in this area (Cardiovascular Diabetology, 2014; BMC Public Health, 2018) funded by the CIHR, Lawson Foundation and the Medavie Foundation.
- The identification of a high prevalence of stigma among youth with type 1 diabetes (Diabetes Canada-funding; JMIR, 2018). This stigma is associated with a greater likelihood of severe hypoglycemia as well as overall glucose levels above target. This led to development of a virtual peer-led peer to peer network to support youth with type 1 diabetes (CIHR and Diabetes Canada-funded).
Please review her publications here.